S&P Futures
4,005.50 -14.25 (-0.35%) Dow Futures
32,074.00 -46.00 (-0.14%) Nasdaq Futures
12,308.50 -74.25 (-0.60%) Russell 2000 Futures
1,783.00 -6.50 (-0.36%) Crude Oil
110.28 -0.21 (-0.19%) Gold
1,800.70 -7.50 (-0.41%)
Axsome Therapeutics, Inc. (AXSM)
After hours:
Chart Events
Performance Outlook
| Previous Close | 25.34 |
| Open | 25.92 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1000 |
| Day's Range | 25.92 - 28.80 |
| 52 Week Range | 19.38 - 74.10 |
| Volume | |
| Avg. Volume | 1,081,711 |
| Market Cap | 1.052B |
| Beta (5Y Monthly) | 2.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.35 |
| Earnings Date | Feb 28, 2022 - Mar 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 86.00 |
- Motley Fool
Is This Biotech a Safe Stock to Buy?
Upon first glance, Axsome Therapeutics (NASDAQ: AXSM) doesn't exactly sound like a candidate for being a safe stock that's ready to buy today. At present, the biotech has no approved drugs nor any revenue. Its drug AXS-05 is its flagship program, and it's being investigated in a late-stage clinical trial for its usefulness in treating agitation in Alzheimer's disease, as well as in another trial for smoking cessation.
- Motley Fool
My Favorite Biotech
Biotech is one of the fastest growing areas in healthcare, and one of the more exciting sectors in the stock market. Here's why three Fool.com contributors are bullish on 10x Genomics (NASDAQ: TXG), Axsome Therapeutics (NASDAQ: AXSM), and Doximity (NYSE: DOCS). 10x Genomics sells the machines and associated consumables that allow scientists to look in and around a single cell, referred to as spatial biology.
- Simply Wall St.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) drops to US$1.1b and insiders who purchased earlier this year lose another US$77k
Insiders who bought US$374k worth of Axsome Therapeutics, Inc.'s ( NASDAQ:AXSM ) stock at an average buy price of...
